CLINICAL TRIAL AGREEMENT THIS AGREEMENT (this“Agreement”) is made and entered into as of the date of disclosure in the Register of Contracts (the "Effective Date") by and between Immunomedics, Inc., a Delaware corporation having a place of business at...Clinical Trial Agreement This Agreement • April 9th, 2019
RÚ: 120.0088019Clinical Trial Agreement This Agreement • January 2nd, 2020
CLINICAL TRIAL AGREEMENT This Agreement (hereinafter "Agreement") is made between (1) Hexal AG lndustriestrasse 25 83607 Holzkirchen Germany (Hexal) and (2) Revmatologický ústav Na Slupi 450/4 128 00 Praha 2 - Nové Město Czech Republic Organization ID No.:00023728 Tax lD No.:CZ00023728 (the lnstitution) (the Principal lnvestigator). Institution shall appoint the Principal Investigator to take responsib1lity to conduct the Tria! and supervise the Trial Personnel on behalf of Institution. WHEREAS, the Institution shall particularly be responsible for ensuring the material conditions of the Tria!as determined in the Tria! protocol and any other written instructions that may be provided by Hexal. WHEREAS, Institution desires to participate m the Tria! as described in this Agreement. SMLOUVA O KLINICKEM HODNOCENI Tato smlouva (dálejen smlouva) se uzavírá mezi (1) Hexal AG Industriestrasse 25 83607 Holzkirchen Německo
